2007
31
Oct
Why Rimonabant Acomplia ?
The European Commission gave permission for the sale of Rimonabant acomplia prescription weight loss drugs to treat obesity and weight loss with a BMI ( body mass index) of 30 or above as well as for smoking cessation treatments. …
More: continued here